Analystreport

Proteostasis Therapeutics Inc (NASDAQ: PTI) had its price target raised by analysts at Robert W. Baird from $13.00 to $25.00.

PROTEOSTASIS THERAPEUTICS  (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview